Skip to content

Efficacy and safety study of low-dose platelets in hematologic pediatric patients

Efficacy and safety study of low-dose platelets in pediatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048894
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematonosis

Interventions

Group 1:low-dose platelet therapy
Group 2:High-dose platelet therapy

Sponsors

Wuhan Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with blood tumor disease; 2. Aged from 1 to 14 years, weighing less than 30kg; 3. Patients with platelet transfusion indications, and who agreed to receive platelet transfusion treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with peripheral blood platelet counts more than 50x10^9 / L; 2. Contraindication for platelet transfusion, heparin-induced thrombocytopenia, thrombocytic thrombocytopenia purpura, hemolytic uremic syndrome, etc.

Design outcomes

Primary

MeasureTime frame
the corrected count increment;the post-transfusion platelet increment;

Countries

China

Contacts

Public ContactHu Hongbing

Wuhan Children's Hospital

whfesx@163.com+86 27 82308597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026